Identification of clinical predictors for dupilumab dose spacing in adults with atopic dermatitis: a real-world study

Background Dupilumab is a monoclonal antibody against the IL-4/IL-13 receptor-subunit approved for the treatment of moderate-severe atopic dermatitis (AD). Some attempts to increase dose interval have been described in both trial and real-world settings. Objective This study aimed to identify predic...

Full description

Saved in:
Bibliographic Details
Main Authors: Andrea Chiricozzi (Author), Giacomo Dal Bello (Author), Niccolò Gori (Author), Lucia Di Nardo (Author), Donatella Schena (Author), Giacomo Caldarola (Author), Martina Maurelli (Author), Clara De Simone (Author), Giampiero Girolomoni (Author), Ketty Peris (Author)
Format: Book
Published: Taylor & Francis Group, 2023-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available